Chronic rhinosinusitis: Future treatments and unmet needs - 04/08/22
Doi : 10.1016/j.jaci.2022.05.016
Sneha Giri, MD, Alexander L. Schneider, MD, Bruce K. Tan, MD, MS ⁎ 
Department of Otolaryngology–Head and Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, Ill
∗Corresponding author: Bruce K. Tan, MD, MS, 676 N Saint Clair St, Suite 1300, Chicago, IL 60611.676 N Saint Clair StSuite 1300ChicagoIL60611
Key words : Chronic rhinosinusitis, type 2 inflammation, biologics, endoscopic sinus surgery
Il testo completo di questo articolo è disponibile in PDF.
Mappa
| Supported by the National Institutes of Health (grants R01 AI134952 and R01 DC016645) and the Chronic Rhinosinusitis Integrative Studies Program 2 (CRISP2) (grant P01, AI145818). |
|
| Disclosure of potential conflict of interest: B. K. Tan reports personal fees from Sanofi Regeneron/Genzyme. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2022
American Academy of Allergy, Asthma & Immunology. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 150 - N° 2
P. 287-290 - Agosto 2022 Ritorno al numero
Articolo precedente
- What can we learn from treating atopic itch in dogs?
- Angelina Labib, Gil Yosipovitch, Thierry Olivry
- Eosinophilic gastrointestinal diseases make a name for themselves: A new consensus statement with updated nomenclature
- Benjamin L. Wright, Justin T. Schwartz, Melanie A. Ruffner, Glenn T. Furuta, Nirmala Gonsalves, Evan S. Dellon, Seema S. Aceves
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?